Your session is about to expire
← Back to Search
Genetic Counseling for Cancer (GIFT Trial)
N/A
Waitlist Available
Led By Steven Katz, MD
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after the 6 month follow up survey
Awards & highlights
GIFT Trial Summary
This trial helps cancer patients and their relatives understand and take action on inherited cancer risks. It provides support and services to get genetic testing and make informed decisions.
Who is the study for?
The GIFT Study is for adults diagnosed with any type of cancer in 2018-2019, as recorded by Georgia or California SEER registries. Participants must carry a genetic variation linked to cancer risk and be alive at the time of selection. It's not open to those under 18.Check my eligibility
What is being tested?
This study tests the GIFT intervention, which aims to help cancer patients inform their relatives about inherited cancer risks and support them in getting genetic testing and making informed decisions on prevention and early detection.See study design
What are the potential side effects?
Since this trial focuses on information sharing and genetic testing rather than medication or procedures, it does not have typical medical side effects. However, participants may experience stress or anxiety related to discussing genetic risks.
GIFT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after the 6 month follow up survey
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after the 6 month follow up survey
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
To determine the independent effects of the two virtual platform design features on relatives' receipt of genetic testing.
Secondary outcome measures
Malignant Neoplasms
Malignant Neoplasms
To determine the independent effects of the two virtual platform design features on the proportion of relatives invited by each patient to enroll in the study.
GIFT Trial Design
4Treatment groups
Experimental Treatment
Group I: Arm 4Experimental Treatment1 Intervention
Arm information details will not be provided at this time in order to preserve scientific integrity and will be updated once the study has resulted.
Group II: Arm 3Experimental Treatment1 Intervention
Arm information details will not be provided at this time in order to preserve scientific integrity and will be updated once the study has resulted.
Group III: Arm 2Experimental Treatment1 Intervention
Arm information details will not be provided at this time in order to preserve scientific integrity and will be updated once the study has resulted.
Group IV: Arm 1Experimental Treatment1 Intervention
Arm information details will not be provided at this time in order to preserve scientific integrity and will be updated once the study has resulted.
Find a Location
Who is running the clinical trial?
University of Michigan Rogel Cancer CenterLead Sponsor
293 Previous Clinical Trials
18,483 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,928,053 Total Patients Enrolled
Steven Katz, MDPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am 18 or older, live in the US, Canada, or Mexico, and haven't had doctor-ordered genetic testing in the last 5 years.I am over 18 and live in the US, Canada, or Mexico.I have had genetic testing for cancer risk and the result was positive.I carry a gene variant linked to cancer risk according to a specific study.I am 18 years old or older.I was diagnosed with cancer in 2018 or 2019 and my case is in the Georgia or California cancer registries.I have not received genetic testing or do not have a positive genetic test result.I am 18 or older, live in the US, Canada, or Mexico, and haven't had genetic testing by a doctor in the past 5 years.
Research Study Groups:
This trial has the following groups:- Group 1: Arm 4
- Group 2: Arm 1
- Group 3: Arm 2
- Group 4: Arm 3
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many healthcare facilities have been enlisted to conduct this clinical trial?
"Currently, this trial is recruiting patients from 4 different medical centres. These are located in Atlanta, Ann Arbor and Los Angeles; other sites may also be available for recruitment closer to your home address. Selecting the most convenient site can help reduce travelling requirements if you choose to participate."
Answered by AI
Do any vacancies remain for potential participants in this clinical trial?
"Evidently, this clinical trial is no longer actively recruiting patients. Initially posted on October 24th 2022 and last updated on March 10th 2023, the study has exhausted its pool of candidates. However, there are presently 537 other trials that still seek participants for their research."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger